Discharge to Home and Chronic Illness Care Pilot
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to address a gap in knowledge needed for care of children with solid organ transplantation (SOT) and their parents by combining mHealth technology with an individualized family centered self-management intervention (referred to as myFAMI). This study is critical to the increased understanding of hospital to home transition and family management at home with the potential to transform the way clinicians approach the care of complex chronic illness children and families.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 12, 2014
CompletedFirst Posted
Study publicly available on registry
June 17, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedMarch 7, 2019
March 1, 2019
4.3 years
June 12, 2014
March 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluate the effectiveness of myFAMI on 30-day post-discharge outcomes.
Hypothesis: Compared to parents who received standard discharge preparation (usual care), parents receiving myFAMI will report: i) Better care coordination, ii) Higher quality of discharge teaching, iii) Greater readiness for hospital discharge, iv) Improved post-discharge coping, v) Improved family functioning, vi) Better self-management of medication and treatment regimens vii) Fewer emergency department visits and hospital readmissions
30 days following enrollment
Secondary Outcomes (1)
Examine the acceptability of myFAMI:
Enrollment plus 30 days
Study Arms (2)
Control
EXPERIMENTALTen parents will be randomized to the control group defined as 'usual care' and ten to the intervention group, stratified by type of transplant.
Intervention
EXPERIMENTALTen parents will be randomized to the control group defined as 'usual care' and ten to the intervention group, stratified by type of transplant.
Interventions
Eligibility Criteria
You may qualify if:
- parent's child has undergone a heart, kidney, or liver transplant and is being discharged home from the hospital
- the parent is English speaking (to date the tools being used have been validated for English participants only)
- parent is 18 years of age or older
- patient is 17 years of age and younger.
You may not qualify if:
- presence of significant communication or cognitive impairment on the part of the parent that would preclude completion of questionnaires based on self-report
- parent and child has experienced the discharge to home transition from a previous transplant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital of Wisconsin
Milwaukee, Wisconsin, 53226, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Stacee Lerret, PhD
Medical College of Wisconsin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 12, 2014
First Posted
June 17, 2014
Study Start
June 1, 2014
Primary Completion
October 1, 2018
Study Completion
October 1, 2018
Last Updated
March 7, 2019
Record last verified: 2019-03